Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

What’s Going On With Intel Stock?

Intel Corporation (NASDAQ: INTC) shares moved higher Monday. The company will report second quarter 2023 financial results on July 27.
byRyan Gustafson
July 17, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Intel Corporation (NASDAQ:INTC) shares moved higher Monday. The company will report second quarter 2023 financial results on July 27.

What To Know: The company is set to report second quarter earnings on Thursday, July 27  2023, promptly after the close of market. Intel will then hold an earnings conference call at 2 p.m. PDT that day to discuss the results.

Intel’s earnings report is preceded by a month of activity for the stock. The company received several price target changes, ranging from $17 to $39.

Other news during the month included China’s announcement of restrictions on the export of metals used in chip production which impacted shares of semiconductor and chip companies.

Related Link: What’s Going On With T-Mobile Stock?

INTC Price Action: Shares of INTC were up 3.82% at $34.42 at the time of publication, according to Benzinga Pro.

Image by Michael Schwarzenberger from Pixabay

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets

By Jelena Martinovic
February 14, 11:03 AM
Medical cannabis company cbdMD has reported financial results for its first quarter of fiscal 2024. Operating loss improved to $1.1m compared to $4.1m for the same period in the previous year. Gross profit was flat at around $3.5m, while operating expenses were $4.6m, down from $7.6m in the previous year. Total net sales declined to $5.37m from almost $6m in the corresponding prior-year period. Direct-to-consumer net sales represented 82.3% of total net sales, a decrease from 90% in Q1 2023. On 31 December 2023, cbdMD had total working capital of roughly $1.4m compared to approximately $3.4m on 30 September, with cash on hand dropping to roughly $1.5m from $1.8m over the same period. The Charlotte-based company recently struck a securities purchase agreement with five institutional investors to fund the national rollout of its ATRx Labs functional mushroom products, as well as launching the hempMD and ATRx Labs brands.

YCBD